Project Name：Diacerein 

Registration Classification：3+6

Formulations and specifications ：Capsules: 50mg 

Indications：For the treatment of degenerative joint disease ( osteoarthritis and related diseases ) . National studies show that the product can significantly improve bone and joint pain, arthritis and related diseases caused by dysfunction and other symptoms . After taking it 2 or 3 weeks, the effect appears  markedly, from 4 to 6 weeks the effect is significant. With three months of continuous treatment withdrawal , the effect lasts for at least a month ( up effect ) .

Original Research Company：TRB Pharma S.A. 

Progress ：Pharmaceutical Research in progress